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Raffaele Pulli,1 Pierluigi Stefano,3 and Carlo Pratesi,1 Florence, ItalyBackground: Aim of this study was to analyze our experience in the last 5 years of combined
carotid and cardiac surgery.
Methods: During a 5-year period (January 2002-December 2006), 111 patients underwent
combined carotid endarterectomy (CEA) and coronary artery bypass grafting (CABG) (group 1),
while 1,446 patients underwent isolated CEA (group 2). Perioperative outcomes in the two groups
were compared using c2 and Fisher’s exact tests to analyze neurological deficits, cardiac events,
and death at 30 days. Results during follow-up were analyzed using KaplaneMeier survival
curves, and both groups were compared using the log-rank test.
Results: Immediate postoperative neurological deficits occurred more frequently in group 1 patients
(2.5 vs. 0.4%, p ¼ 0.002), with a higher incidence of transient ischemic attacks in group 1; however,
there was no difference in the incidence of stroke (1% group 1 vs. 0.6% group 2, p ¼ n.s.). Mortality
rate was increased in the combined surgery group (3.5 vs. 0.5%, p < 0.001). Combined stroke/
myocardial infarction/death rate at 30 days was 6.3% in group 1 compared with 1.4% in group 2,
p ¼ 0.001. Perioperative stroke/myocardial infarction/death rate was much improved in the 55%
(61/111) of patients undergoing CABG off-pump (3.3 vs. 10%, p ¼ 0.001). Mean follow-up was
18.7 months (range, 1-60). Survival at 24 months was significantly higher in patients of group 2
compared with group 1 (99.4 vs. 91.3% respectively, p < 0.001). At 24 months, there was no signif-
icant difference between the two groups in the risk of developing ipsilateral or contralateral neurologic
events (3.1% group 1 vs. 1.7% group 2).
Conclusion: In our experience, combined CEA and cardiac surgery carries a higher risk of
perioperative mortality than patients undergoing isolated CEA. Whenever possible, CEA
combined with off-pump CABG seems to be the therapeutic strategy of choice.INTRODUCTION
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ne: --,-endarterectomy (CEA) or coronary artery bypass
grafting (CABG) frequently have systemic athero-
sclerotic disease. Approximately 28% of patients
who are candidates for CEA have significant correct-
able coronary artery disease; 12% of patients under-
going myocardial revascularization are noted to
have carotid artery stenosis of more than 80%,
and 22% of patients undergoing CABG have >
50% carotid stenosis.1-3
In addition, coronary artery disease contributes
in large part to the perioperative and long-term
mortality of patients undergoing CEA. Even in
patients in whom CEA is not indicated, atheroscle-
rosis is considered an important marker of coronary
sclerosis.4 In asymptomatic patients with carotid
stenosis, the annual risk of myocardial infarction is1
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ipsilateral stroke. In contrast, the percentage of peri-
operative neurological events occurring during
CABG varies between 1 and 5.2%.5 Various mecha-
nisms have been proposed for these events: athero-
sclerotic plaques of the ascending aorta,
intraventricular thrombus, gaseous microemboliza-
tions, lipidic particles, thrombus forming during
CABG surgery, carotid thromboembolic events,
and cerebral hypoperfusion.6,7
Because of the multifactorial nature of these
neurological events, the management of carotid
arterial stenosis in patients who are candidates for
CABG remains controversial. Proposed therapeutic
strategies have included simultaneous CEA-CABG,
staged or reverse staged procedures, performing
only CABG, carotid artery stenting (CAS) before
CABG, and the use of off-pump CABG.8-10
However, despite multiple studies, there remain
no generally accepted guidelines for the optimal
therapeutic approach to adopt in this subgroup of
patients.
The purpose of this study was to analyze our
experience in the last 5 years of combined CEA
and cardiac surgery, with the aim of highlighting
short and mid-term results, possible risk factors,
and comparing outcome to a control group of
patients undergoing isolated CEA during the same
period.MATERIALS AND METHODSStudy GroupOver a 5-year period (January 2002-December
2006), 1,557 consecutive CEA procedures were per-
formed by the Department of Vascular Surgery of
the University of Florence. In 111 of these cases,
CEA and cardiac surgery were performed simulta-
neously (group 1), while the remaining 1,446
patients underwent isolated CEA (group 2). All
data regarding the operations performed were
prospectively entered into a database, including
preoperative assessment, surgical techniques and
intraoperative neurologic monitoring, immediate
and 30-day perioperative outcomes, and mid-term
follow-up.Preoperative EvaluationAll patients preoperatively underwent clinical
history and physical examination; a two-view chest
X-ray; laboratory tests, including complete blood
count, coagulative parameters, and blood chemis-
tries; an electrocardiogram; an echocardiography;a cardiac consultation; and a Duplex ultrasound
scanning of extra-cranial vessels. Coronary angiog-
raphy was performed in all group 1 patients.
Furthermore, all patients underwent preopera-
tive computerized tomography angiography or
magnetic resonance imaging/angiography with
evaluation of the aortic arch and carotid arteries,
the cerebral circulation and parenchyma.
Indications for carotid surgery were carotid
stenosis 70% in asymptomatic patients and 
50% in symptomatic ones; the degree of carotid
stenosis was determined on the basis of NASCET
criteria. Our indications did not differ whether the
patient underwent combined carotid and cardiac
surgery.
Patients were considered to be asymptomatic in
the absence of neurological symptoms (transient
ischemic attacks [TIA] or stroke) within 6 months
from the intervention.Surgical StrategySurgery for group 1 patients was carried out in
collaboration with the Department of Cardiac
Surgery of the Careggi Hospital in Florence. In all
cases of combined surgery, the cardiosurgical opera-
tion always followed the CEA carried out under
general anesthesia.
Before clamping the carotid artery, the patient
was administered 30 IU/kg bolus heparin. Stump
pressures were not measured. Cerebral function
was monitored with somatosensory evoked poten-
tials (SEPs) with selective use of a carotid shunt in
cases of critical reduction (>50%) in SEPs. After
CEA completion, cardiac surgery was performed
with heparin supplemented to reach an ACT of
greater than 500 seconds. In cases of surgery under
cardiac arrest, the aorta was connected to the right
atrium with a ‘‘two stage’’ cannula and initiation
of cardiopulmonary bypass.
Isolated CEA surgery was executed using the
same surgical strategy and anesthesia described in
previous articles from our center, which involve
extensive use of locoregional anesthesia with clin-
ical monitoring of cerebral function, routine use of
preliminary clamping of the internal carotid artery,
reconstruction with patch angioplasty in most cases,
intraoperative quality control with duplex and in
some cases with angiography.11Postoperative Management and
Follow-upGroup 1 patients were typically hospitalized in the
cardiac surgery ward 2 days before surgery, and
transferred to the intensive care unit at the
Table I. Demographic characteristics and
comorbidities
Characteristics Group 1 Group 2 p
Age 73.2 72.3 0.02
Male sex 82 (74%) 1,017 (70%) NS
Hypertriglyceridemia 37 (33%) 431 (30%) NS
Hypercholesterolemia 47 (42%) 655 (45%) NS
Hypertension 78 (70%) 1,059 (73%) NS
Diabetes 34 (30%) 281 (19%) 0.01
Smoker 13 (11%) 241 (16%) NS
Ex-smoker 56 (50%) 739 (51%) NS
PAOD 46 (41%) 387 (26%) 0.001
Ischemic cardiopathy 111 (100%) 249 (17%) < 0.001
Table II. Clinical characteristics of patients
Characteristics Group 1 Group 2 p
Q1
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therapy unit and wards equipped to carry out
cardiac rehabilitation which lasted for approxi-
mately 10 days. Patients in group 2, at the end of
surgery, were transferred to a general hospital
ward or, in some cases, to intensive or subintensive
therapy units for monitoring.
Neurological outcomes during hospital stay were
assessed by a vascular surgeon. Neurological evalu-
ation at 30 days was independently performed in all
patients by an experienced neurologist to evaluate
the presence of any differences respect to the preop-
erative period about the neurological status.
Moreover, follow-up was performed at 1, 6, 12
months, and yearly thereafter by carotid Duplex
scanning. All studies were performed using an Acu-
son Sequoia 512 Ultrasound System (Acuson
Corporation, Mountain View, CA).Asymptomatic 105 (95%) 965 (66%) < 0.001
TIA 5 (4%) 265 (18%) < 0.001Statistical Analysis
Minor stroke 1 (1%) 55 (4%) 0.001
Major stroke 0 14 (1%) NS
Vertebrobasilar 0 108 (8%) < 0.001
Acute 0 39 (3%) NS
Table III. Anatomical and morphological
characteristics
Characteristics Group 1 Group 2 pPerioperative results in the two groups were
compared using the c2 test and Fisher’s exact test
to analyze neurological deficits, cardiac events,
and death at 30 days. The results during follow-up
were analyzed using KaplaneMeier survival curves,
and outcomes of both groups were compared using
the log-rank test. Statistical analysis was carried out
using the SPSS 15.0 for Windows software (SPSS
Inc., Chicago, IL).Degree of stenosis
60e79%
41 (37%) 627 (43%) NS
Degree of stenosis
80e99%
69 (62%) 753 (52%) NSRESULTSPseudo-occlusion 1 (1%) 55 (4%) NSAnatomical-Clinical Characteristics
Aneurysm/
pseudoaneurysm
0 11 (1%) NS
Contralateral occlusion 6 (5%) 78 (5%) NS
Primary lesion 101 (91%) 1,207 (83%) NS
Restenosis 1 (1%) 57 (5%) NS
Prior contralateral CEA 9 (8%) 182 (12%) NSPatient demographics of the two groups are shown
in Table I. There were significantly higher rates of
diabetes, peripheral artery disease, and ischemic
heart disease in group 1 patients. The majority of
patients in both groups were asymptomatic from
a neurologic standpoint, but especially in group 1
(95 vs. 66%, p < 0.001). Carotid artery stenosis in
group 1 was often incidentally found as a result of
a routine preoperative cardiosurgical screening
program. Among the symptomatic patients, the
most frequently encountered clinical presentation
was TIA in both groups. In group 2, 39 patients
were treated acutely or 6% of the total patients
(Table II).
The anatomical and morphological characteris-
tics of the carotid lesions in the two groups of
patients are shown in Table III. Therewere no differ-
ences in the two groups regarding type of carotid
pathology (primary or recurrent stenosis), incidenceof contralateral carotid occlusion, or prior contralat-
eral CEA.Intraoperative CharacteristicsThe 111 patients who underwent combined surgery
were administered general anesthesia and intrao-
perative cerebral monitoring was based on the use
of SEPs with selective use of a carotid shunt on the
basis of wave modifications N20/P25.11 In contrast,
in group 2 it was possible to use local anesthesia in
almost half of the patients, with direct neurological
Table IV. Type of anesthesia and intraoperative
cerebral protection
Method Group 1 Group 2 p
General anesthesia 111 (100%) 730 (51%) < 0.001
Local anesthesia 0 716 (49%) < 0.001
Shunt for SEPs
reduction or
clinical alterations
3 (3%) 128 (9%) 0.02
Routine shunt use 4 (4%) 27 (2%) NS
Table V. Type of carotid reconstruction
Technique Group 1 Group 2 p
Direct suturing 3 (3%) 137 (9%) NS
Patch 104 (87%) 1,258 (93%) NS
Bypass/graft 3 (3%) 17 (1%) NS
Eversion 1 (1%) 34 (2%) NS
Carotid clamp
time (min)
31 30 NS
Table VI. Cardiosurgery associated with CABG
Associated valvular 21 19%
4 Chiti et al. Annals of Vascular Surgery
ARTICLE IN PRESSmonitoring of the cooperative patient. Selective use
of a carotid shunt was seen mainly in group 2 rather
than group 1 (9 vs. 3%, p¼ 0.02); however, routine
shunt rates were similar (Table IV). CEA was per-
formed with application of a patch in the majority
of cases, and carotid clamp times were similar in
both groups (Table V).
Cardiac surgery consisted of myocardial revascu-
larization in all cases. Cardiac surgery was carried
out using cardiopulmonary bypass in 50 cases
(45%) and was associated with other types of oper-
ations in 24 cases, as indicated in Table VI. Off-pump
CABG was performed in 61 cases (55%).
The medium left ventricular ejection fraction in
patients of group 1 was 47% (range, 30-60%). The
mean number of bypasses performed was 2.6 ± 1.1
(range, 1-5), whereas the mean duration of
cardiopulmonary bypass was 79.9 ± 31 min (range,
35-215).
Group 1 patients were hospitalized after surgery
for a mean of 3.3 ± 6.6 days in the intensive care
unit (range, 1-53). Total preoperative and postoper-
ative hospitalization was on average 11.1 ± 5.4 days
(range, 4e29).
Septum myomectomy 1 0.9%
Ventriculoplasty 2 1.8%Short-Term ResultsWe observed a higher incidence of immediate post-
operative neurological deficit in group 1 patients,
2.5 versus 0.4% ( p ¼ 0.002), but this was mostly
attributable to a higher incidence of TIA in this
group. There was no difference in the incidence of
stroke between the two groups at 30 days (1%group
1 vs. 0.6% group 2, p ¼ n.s.).
As expected, there was a higher perioperative
mortality rate in the cardiac surgery group, 3.5
versus 0.5% ( p< 0.001), linked primarily to cardiac
complications (Table VII). At 30 days postsurgery,
four patients of group 1 had died: one due to
myocardial infarction, two due to multiorgan
failure, and one due to complications of aspiration
pneumonia. Three of four cases had undergone
CABG using cardiopulmonary bypass. The single
minor stroke that occurred in group 1 was also in
a patient undergoing CABG with cardiopulmonary
bypass. Perioperative stroke/myocardial infarction/
death rate was much improved in the 55% (61/
111) of patients undergoing CABG off-pump (3.3
vs. 10%, p ¼ 0.001).Long-Term ResultsMean follow-up was 18.7 months (range, 1-60).
Estimated survival at 24 months was significantly
higher in group 2 compared with group 1 (99.4 vs.
91.3% respectively, p< 0.001) (Fig. 1). The primarycause of death during follow-up in both groups was
cardiac disease. At 24 months, there was no signifi-
cant difference in the risk of subsequent neurologic
events between the two groups (3.1 and 1.7%, p ¼
n.s., respectively), and the incidence of significant
carotid restenosis (>70%) was 8% in group 1 and
11% in group 2 ( p ¼ n.s.).DISCUSSION
The incidence of neurological complications after
coronary artery bypass has remained essentially
unchanged over the past three decades with a 2%
incidence of stroke.12,13 Stroke is certainly one of
the most feared complications following CABG,
with a 24.8% mortality and mean hospital stay for
survivors of 28 days.5-7 Multiple risk factors for
stroke in patients undergoing CABG have been
identified, including age, preoperative neurologic
symptoms, aortic arch disease, carotid bruit, dia-
betes, and degree of carotid stenosis. The heteroge-
neity of these factors suggests that the etiology of
post-CABG stroke is certainly multifactorial and
interlinked. In the high-risk subgroup of patients
noted to have coexistent carotid disease; it has
been estimated that 40-50% of post-CABG strokes
Table VII. Thirty-day outcomes
Event Group 1 Group 2 p
Immediate neurological
deficit
3 (2.5%) 6 (0.4%) 0.002
TIA 3 (2.5%) 1 (0.1%) < 0.001
Minor stroke 1 (1%) 7 (0.5%) NS
Major stroke 0 1 (0.1%) NS
Myocardial infarction
(MI)
2 (1.8%) 8 (0.5%) 0.05
Mortality 4 (3.5%) 7 (0.5%) < 0.001
Total stroke/MI/death 7 (6.3%) 21 (1.4%) 0.001
Fig. 1. Estimated 24-month survival (KaplaneMeier
curve).
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optimal strategy in these patients remains
controversial.12,13
Proposed therapeutic strategies to decrease the
risk of post-CABG stroke in patients with coexistent
carotid disease have included simultaneous CEA-
CABG, staged or reverse staged procedures, per-
forming only CABG, CAS before CABG, and the
use of off-pump CABG. However, despite multiple
studies there remain no generally accepted guide-
lines for the optimal therapeutic approach to adopt
in this subgroup of patients, and no randomized
prospective studies have been performed.
Naylor et al. have published several thorough
reviews of the literature concerning patients pre-
senting with concomitant carotid and coronary
disease.13-16 In an initial review of 59 studies, they
noted that 91% of screened CABG patients had no
significant carotid disease and stroke risk in these
patients was less than 2%. Stroke risk increased to
3% in predominantly asymptomatic patients withunilateral 50-99% carotid stenosis, 5% in those
with bilateral 50-99% carotid disease, and 7-11%
in patients with carotid occlusion.13
In a subsequent review of 97 published studies
following 8,972 staged or combined procedures, Nay-
lor et al. noted the highest operative mortality occur-
ring in patients undergoing CEA and CABG
simultaneously (4.6%, 95% C.I.), whereas the
reverse staged treatment (CABG followed by CEA)
carried the highest risk of ipsilateral stroke (5.8%,
95% C.I.) and stroke in general (6.3%, 95% C.I.).
Myocardial infarction had the lowest perioperative
risk in patients operated with the reverse staged
procedure (0.9%, 95% C.I.) and the highest in
patients undergoing the combination surgery (CEA-
CABG) (6.5%, 95% C.I.). The risk of death/myocar-
dial infarction/strokewas11.5%(95%C.I.) following
simultaneous surgery compared with 10.2% (95%
C.I.) in staged procedures (CEA, CABG). Overall,
they concluded there were no statistically significant
differences between the two strategies.14
High-risk subgroups of patients for post-CABG
stroke include not only patients with carotid disease,
but also neurologically symptomatic patients, and
patients with aortic arch disease. In a review of
9,939 patients in 8 published series, patients with
a previous TIA or stroke had an 8.5% risk of perio-
perative stroke compared with 2.2% stroke risk in
those patients who are neurologically asymptom-
atic.13 In a review of 10 studies for a total of 111
patients suffering stroke after CABG, 48% of these
patients did not have particularly significant disease
in either carotid (<50% stenosis), 20% had 50-99%
unilateral stenosis, 20% had 50e99% bilateral
stenosis, 7% carotid occlusion with <50% contra-
lateral stenosis, and 4% an occlusion with >50%
contralateral stenosis and 1% bilateral occlusion.
These data, together with those from CT scans and
autopsies (frequent multifocality of the stroke),
suggest that only 50% of strokes in CABG patients
may be attributed to carotid artery disease. It is
therefore important to understand the state of the
aorta, the choice of site and aortic clamping tech-
nique, and to use the off-pump surgical method,
with the aim of limiting noncarotid adverse neuro-
logical events.12 Observational studies have
reported significant reductions in the risk of post-
CABG stroke using off-pump CABG; however,
most of these studies did not analyze the high-risk
subgroup of patient presenting with combined
carotid and coronary disease. However, in a review
of 12 studies including 324 synchronous CEA plus
off-pump CABG procedures, the operativemortality
was only 1.5% and the risk of death or any stroke
significantly reduced at 2.2%.15
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also been proposed as an alternative to combined
CEA-CABG. The theoretical advantages of carotid
stenting are linked to its lower invasivity and avoid-
ance of general anesthesia, which may reduce
cardiac risks.12 However, a recent review of 11 pub-
lished studies demonstrated in 760 CAS plus CABG
procedures indicated an overall mortality of 5.5%
and a 30 day risk of death/any stroke of 9.1%. The
majority of patients (87%) were neurologically
asymptomatic questioning the prophylactic value
of this strategy in post-CABG stroke prevention.16
In our experience, combined surgery with CEA
and cardiac surgery (revascularization with or
without valve substitution) carried a risk of
mortality at 30 days postsurgery, which is signifi-
cantly higher in comparison with those patients
undergoing isolated CEA. In reality, the increased
risk is mainly correlated with increased cardiovas-
cular mortality, whereas neurological complications
of the combined surgery remained extremely low
and similar to those obtained with isolated CEA.
Similar to other series of combined CEA and off-
pump CABG, we noted a marked reduction in peri-
operative stroke/myocardial infarction/death rates
in patients undergoing CEA with off-pump CABG
(3.3 vs. 10%, p ¼ 0.001).
Clearly the patient who presents with significant
carotid and coronary disease is almost always an
individual in compromised clinical condition, which
is manifested in the increase in perioperative risk
and reduction in survival during follow-up. Our
study at 24 months showed a decreased survival in
patients requiring combined CEA-CABG versus iso-
lated CEA (85 vs. 98.8%). However, freedom from
subsequent stroke at 24 months (3.1 vs. 1.7%) and
freedom from significant carotid restenosis (8 vs.
11%) were comparable in both groups.
In our opinion, the elevated incidence of perio-
perative neurological events in patients undergoing
cardiac surgery who present with carotid disease,
even if asymptomatic, warrants an aggressive
prophylactic approach if results document minimal
perioperative mortality and protection from subse-
quent neurological events in the short and long
term. Our results would also suggest significantly
improved results in patients undergoing combined
CEA with off-pump CABG.CONCLUSIONS
In our experience, combined CEA and cardiac
surgery carries a higher risk of perioperative
mortality than patients undergoing isolated CEA;however, this increased risk was mainly related to
cardiovascular mortality. Neurologic outcomes of
the combined surgery remained extremely low
with perioperative andmid-term stroke rates similar
to CEA alone. Whenever possible, CEA combined
with off-pump CABG seems to be the therapeutic
strategy of choice.REFERENCES
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